Xiangwei Hua Selected Research

SB 216763

4/2019	Inhibition of glycogen synthase kinase 3β protects liver against ischemia/reperfusion injury by activating 5' adenosine monophosphate-activated protein kinase-mediated autophagy.
1/2018	Inhibition of GSK-3β induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangwei Hua Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2019
2	Liver Diseases (Liver Disease) 01/2022 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2019
1	Hepatitis 01/2022
1	Autoimmune Hepatitis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Hypoxia (Hypoxemia) 04/2019
1	Necrosis 04/2019
1	Reperfusion Injury 04/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Cholestasis 01/2017

Drug/Important Bio-Agent (IBA)

2	karonudibIBA 01/2022 - 01/2019
2	SB 216763IBA 04/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 04/2019 - 01/2017
1	AntigensIBA 01/2022
1	Concanavalin AIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 04/2019
1	Glycogen Synthase KinasesIBA 04/2019
1	Adenosine Monophosphate (AMP)IBA 04/2019
1	MutagensIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Glycogen Synthase (Synthase I)IBA 01/2018
1	OsteopontinIBA 01/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018

Therapy/Procedure

1	Immunotherapy 01/2021
1	Therapeutics 01/2019